首页 | 本学科首页   官方微博 | 高级检索  
     

miR-206靶向MAPK-1通路增强胶质瘤细胞放射敏感性
引用本文:闻公灵,张保朝,万里新,温昌明,王旸,张凯,饶石磊,张敬伟,刘扬帆. miR-206靶向MAPK-1通路增强胶质瘤细胞放射敏感性[J]. 中华放射肿瘤学杂志, 2016, 25(7): 759-763. DOI: 10.3760/cma.j.issn.1004-4221.2016.07.021
作者姓名:闻公灵  张保朝  万里新  温昌明  王旸  张凯  饶石磊  张敬伟  刘扬帆
作者单位:473009 郑州大学附属南阳医院南阳市中心医院神经内科(闻公灵、张保朝、温昌明),肿瘤科(万里新、张敬伟、刘扬),放疗科(王旸、张凯、饶石磊)
基金项目:河南省医学科技攻关计划项目(201403205)Project of Medical Science and Technology Project of Henan Province (201403205)
摘    要:目的 研究miR-206对胶质瘤细胞放射敏感可能作用的信号通路,为深入研究其调控机理奠定基础。方法 将miR-206模拟剂或miR-206抑制剂转染到胶质瘤U87细胞中,使用抑制剂PD98059抑制MAPK通路活性并照射处理细胞,MTT和克隆形成实验检测细胞放射敏感性变化。分别用qRT-PCR和蛋白印迹法检测miR-206和MAPK1的表达变化,TargetScan软件预测和双荧光素酶报告实验验证miR-206和MAPK1的相互作用。结果 胶质瘤细胞放射处理后miR-206表达下调,MAPK1表达上调。miR-206模拟剂过表达miR-206,细胞增殖和克隆形成能力下降,放射敏感性增高;转染抑制剂抑制miR-206表达,细胞增殖和克隆形成能力加强,放射敏感性降低。使用TargetScan软件查找发现MAPK1可能是miR-206的靶基因,双荧光素酶报告实验进一步验证了miR-206和MAPK1具有相互作用。过表达或降低miR-206表达,MAPK1与miR-206呈相反变化趋势。使用抑制剂抑制MAPK信号通路,胶质瘤细胞放射敏感性升高。结论 miR-206可能靶向MAPK1,通过抑制MAPK信号通路活性调节胶质瘤细胞的放射敏感性。

关 键 词:miR-206基因  MAPK1通路  U87细胞系  放射敏感性  基金项目:河南省医学科技攻关计划项目(201403205)  
收稿时间:2016-03-31

miR-206 enhances radiosensitivity of glioma cells by targeting MAPK1 pathway
Wen Gongling,Zhang Baochao,Wan Lixin,Wen Changming,Wang Yang,Zhang Kai,Rao Shilei,Zhang Jingwei,Liu Yangfan. miR-206 enhances radiosensitivity of glioma cells by targeting MAPK1 pathway[J]. Chinese Journal of Radiation Oncology, 2016, 25(7): 759-763. DOI: 10.3760/cma.j.issn.1004-4221.2016.07.021
Authors:Wen Gongling  Zhang Baochao  Wan Lixin  Wen Changming  Wang Yang  Zhang Kai  Rao Shilei  Zhang Jingwei  Liu Yangfan
Affiliation:Department of Nuerology (Wen GL,Zhang BCH,Wen CHM),Department of Onclogy (Wan LX,Zhang JW,Liu Y),Department of Radiation Oncology (Wang Y,Zhang K,Rao SHL),Nanyang Central Hospital, Nanyang Hospital Affiliated to Zhengzhou University,Nanyang 473009,China
Abstract:Objective To investigate the signaling pathway probably targeted by miR-206 in regulation of the radiosensitivity of glioma cells,and to provide a basis for further understanding of its regulatory mechanism.Methods The miR-206 mimic or miR-206 inhibitor was transfected into U87 glioma cells.The activity of the MAPK pathway was inhibited by PD98059.The cells were exposed to radiation.MTT assay and colony formation assay were used to determine the changes in the radiosensitivity of cells.Quantitative RT-PCR and Western blot were used to determine the expression of miR-206 and MAPK1,respectively.TargetScan prediction and dual luciferase reporter system were used to verify the interaction between miR-206 and MAPK1.Results After exposure to radiation,the glioma cells had downregulated expression of miR-206 and upregulated expression of MAPK1.Overexpression of miR-206 induced by the miR-206 mimic reduced cell proliferation and colony formation ability and enhanced the radiosensitivity;inhibition of miR-206 expression by the miR-206 inhibitor reversed the effects of the miR-206 mimic.MAPK1 was predicted to be the possible target gene of miR-206 by TargetScan software.The dual luciferase reporter assay further confirmed the interaction between miR-206 and MAPK1.The expression of MAPK1 was negatively correlated with that of miR-206.The radiosensitivity of glioma cells was enhanced when the MAPK pathway was blocked by the inhibitor.Conclusions miR-206 probably targets MAPK1.It may regulate the radiosensitivity of glioma cells by inhibiting the activity of the MAPK signaling pathway.
Keywords:miR-206 gene  MAPK1 pathway  U87 cell line  Radiosensitivity
本文献已被 万方数据 等数据库收录!
点击此处可从《中华放射肿瘤学杂志》浏览原始摘要信息
点击此处可从《中华放射肿瘤学杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号